Analyst
NBG Invest
Equibles does not estimate personal net worth.
Komal Aya is recorded as Analyst at NBG Invest. Komal Aya has spoken on 1 earnings call across 1 company, most recently for Beta Drugs Limited on May 15, 2026. The companies whose calls Komal Aya spoke on are classified in the Healthcare sector.
“I wanted to know about this flattened business in continuation of the last question. So you said, I wanted to know if you all have stopped flattened completely.”
NBG Invest
Analyst
Transcript header (unverified)
Beta Drugs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Beta Drugs Limited
